logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12759982 B1

PDFFull Text
Date of Patent:
Oct. 13, 2026

Filed:

Apr. 15, 2021

Aryl or heteroaryl derivative

Applicant:

Teijin Pharma Limited, Tokyo, JP;

Inventors:

Sakae Sugiyama, Tokyo, JP;

Takuya Yokosaka, Tokyo, JP;

Kunio Minamizono, Tokyo, JP;

Asahi Kawana, Tokyo, JP;

Toshiyuki Kaneko, Tokyo, JP;

Akinobu Maruyama, Tokyo, JP;

Kosuke Sasaki, Tokyo, JP;

Shinnosuke Hosoda, Tokyo, JP;

Masaki Koshimizu, Tokyo, JP;

Susumu Takeuchi, Tokyo, JP;

Kenta Kato, Tokyo, JP;

Nagasree Chakka, Lexington, MA (US);

Brett M. Johnson, South Weymouth, MA (US);

Ryan D. White, Somerville, MA (US);

Wei Zhao, Westford, MA (US);

Assignee:

Teijin Pharma Limited, Tokyo, JP;

Attorneys:

McCarter & English, LLP

Xin Zhang

Zhongyu “Alex” Wang

Primary Examiner:

Andrew D Kosar

Assistant Examiner:

Jonathan D Mahlum

Int. Cl.
CPC ...
C07D 239/42 (2006.01); C07D 213/30 (2006.01); C07D 231/20 (2006.01); C07D 237/14 (2006.01); C07D 237/22 (2006.01); C07D 239/34 (2006.01); C07D 239/47 (2006.01); C07D 239/48 (2006.01); C07D 239/52 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07D 409/12 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 487/12 (2006.01); C07D 491/052 (2006.01); C07D 491/107 (2006.01); C07D 498/08 (2006.01);
U.S. Cl.
CPC ...
C07D 239/42 (2013.01); C07D 213/30 (2013.01); C07D 231/20 (2013.01); C07D 237/14 (2013.01); C07D 237/22 (2013.01); C07D 239/34 (2013.01); C07D 239/47 (2013.01); C07D 239/48 (2013.01); C07D 239/52 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 409/12 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 487/12 (2013.01); C07D 491/052 (2013.01); C07D 491/107 (2013.01); C07D 498/08 (2013.01);
Abstract

A compound indicated by formula (I) or a pharmacologically acceptable salt thereof is provided as a compound that can be a therapeutic or prophylactic drug for TRPC6-related diseases, such as nephrotic syndrome, membranous nephropathy, acute renal failure, septicemia, chronic renal failure, diabetic nephropathy, pulmonary hypertension, acute lung injury, heart failure, malignant tumor, and muscular dystrophy. (In the formula, Ar, Ar, X-X, R, R, R, R, L, and Lare as defined in the specifications.)

Find Patent Forward Citations

Sugiyama, Sakae. (2026). Aryl or heteroaryl derivative (U.S. Patent No. 12759982). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12759982

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…